Pharma, Biotech Players Step Up Efforts Against Co
Post# of 154090
(Total Views: 573)
Posted On: 03/28/2020 12:20:39 PM
Pharma, Biotech Players Step Up Efforts Against Coronavirus
Leronlimab brief mention in a broad Nasdaq.com & Zacks article...
www.nasdaq.com/articles/pharma-biotech-players-step-up-efforts-against-coronavirus-2020-03-27
New Entries:
Meanwhile, several companies are trying to bring a safe vaccine/drug to stop the pandemic amid this crisis. New names have joined the bandwagon during the week to bring an effective treatment option for coronavirus. Among large players, Swiss-based Roche received FDA approval to initiate a phase III study to evaluate its rheumatoid arthritis drug, Actemra, as a potential treatment for hospitalized adult patients with severe COVID-19 pneumonia. Roche currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Meanwhile, Dynavax Technologies has collaborated with China-based Clover Biopharmaceuticals as well as CEPI, a partnership between public, private, philanthropic, and civil organizations, to develop a vaccine to prevent COVID-19. Hoth Therapeutics and Voltron Therapeutics will form a joint venture to develop a Self-Assembling Vaccine for the potential prevention of COVID-19. CytoDyn Inc. initiated dosing of COVID-19 patients with its multiple therapeutic candidate, leronlimab.
Leronlimab brief mention in a broad Nasdaq.com & Zacks article...
www.nasdaq.com/articles/pharma-biotech-players-step-up-efforts-against-coronavirus-2020-03-27
New Entries:
Meanwhile, several companies are trying to bring a safe vaccine/drug to stop the pandemic amid this crisis. New names have joined the bandwagon during the week to bring an effective treatment option for coronavirus. Among large players, Swiss-based Roche received FDA approval to initiate a phase III study to evaluate its rheumatoid arthritis drug, Actemra, as a potential treatment for hospitalized adult patients with severe COVID-19 pneumonia. Roche currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Meanwhile, Dynavax Technologies has collaborated with China-based Clover Biopharmaceuticals as well as CEPI, a partnership between public, private, philanthropic, and civil organizations, to develop a vaccine to prevent COVID-19. Hoth Therapeutics and Voltron Therapeutics will form a joint venture to develop a Self-Assembling Vaccine for the potential prevention of COVID-19. CytoDyn Inc. initiated dosing of COVID-19 patients with its multiple therapeutic candidate, leronlimab.
(3)
(0)